Effects of neonatal dexamethasone or methylprednisolone on rat growth and neurodevelopment

Pediatrics International

Volumn 50, Issue 4, 2008, Pages 489-494

  Kilic, Ilknur ^a   Dagdeviren, Erol ^a   Kaya, Ertugrul ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Dexamethasone; Growth; Methylprednisolone; Neurodevelopment; Rat

Indexed keywords

DEKORT; DEXAMETHASONE; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; GROWTH DISORDER; MALE; NERVE CELL DIFFERENTIATION; NEUROPSYCHOLOGICAL TEST; NEWBORN CARE; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPRAGUE DAWLEY RAT; TOXICITY TESTING; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; DEXAMETHASONE; GLUCOCORTICOIDS; GROWTH AND DEVELOPMENT; METHYLPREDNISOLONE; NERVOUS SYSTEM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 50249121937     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02588.x     Document Type: Article

References (20)

1. Grier DG, Halliday HL. Management of bronchopulmonary dysplasia in infants. Guidelines for corticosteroid use. Drugs 2005 65 : 15 29.
2. Yeh TF, Lin YJ, Huang CC et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics 1998 101 : E7.
3. Berry MA, Abrahamowicz M, Usher RH. Factors associated with growth of extremely premature infants during initial hospitalization. Pediatrics 1997 100 : 640 46.
4. Gibson A, Pearse R, Wales J. Growth retardation after dexamethasone administration: Assessment by knemometry. Arch. Dis. Child. 1993 69 : 505 9.
5. Shrivastava A, Lyon A, McIntosh N. The effect of dexamethasone on growth, mineral balance and bone mineralization in preterm infants with chronic lung disease. Eur. J. Pediatr. 2000 159 : 380 84.
6. Andre P, Thebaud B, Odievre MH et al. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease. Intensive Care Med. 2000 26 : 1496 500.
7. Flagel SB, Vazquez DM, Watson SJ, Neal CR. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002 282 : R55 63.
8. Bruder ED, Lee PC, Raff H. Dexamethasone treatment in the newborn rat: Fatty acid profiling of lung, brain, and serum lipids. J. Appl. Physiol. 2005 98 : 981 90.
9. Neal CR, Weidemann G, Kabbaj M, Vazquez DM. Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004 287 : R375 85.
10. Bakker JM, Kavelaars A, Kamphuis PJ, Zijlstra J, van Bel F, Heijnen CJ. Neonatal dexamethasone treatment induces long-lasting changes in T-cell receptor vβ repertoire in rats. J. Neuroimmunol. 2001 112 : 47 54.
11. Benesova O, Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989 28 : 89 97.
12. De Vries WB, Van Der Leij FR, Bakker JM et al. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr. Res. 2002 52 : 900 906.
13. Leib SL, Heimgartner C, Bifrare Y, Loeffler JM, Taber MG. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. 2003 54 : 353 7.
14. Dchimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In : Hardman JG, Limbird LE (eds). Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill, New York, 1996 14 66.
15. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed. 1998 79 : F26 F33.
16. Halliday HL. A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant. Prenatal Neonatal Med. 1997 2 : 1 12.
17. O'Shea TM, Kothadia J, Klinepeter KL et al. Randomized placebo-controlled trial of 42-days tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics 1999 104 : 15 21.
18. Ferguson SA, Holson RR. Neonatal dexamethasone on day 7 causes mild hyperactivity and cerebellar stunting. Neurotoxicol. Teratol. 1999 21 : 71 6.
19. Murphy BP, Inder TE, Huppi PS et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001 107 : 217 21.
20. Thebaud B, Lacaze-Masmonteil T, Watterberg K. Postnatal glucocorticoids in very preterm infants: "The good, the bad, and the ugly"? Pediatrics 2001 107 : 413 15.